SBC Medical Group Holdings Incorporated
SBC
$3.57
-$0.07-1.92%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 178.46M | 188.19M | 197.94M | 205.42M | 223.34M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 178.46M | 188.19M | 197.94M | 205.42M | 223.34M |
| Cost of Revenue | 46.23M | 43.34M | 43.67M | 49.37M | 57.80M |
| Gross Profit | 132.23M | 144.86M | 154.26M | 156.05M | 165.55M |
| SG&A Expenses | 69.56M | 84.18M | 81.51M | 82.68M | 94.21M |
| Depreciation & Amortization | 1.64M | 1.62M | 1.41M | 1.91M | 1.91M |
| Other Operating Expenses | 702.30K | 783.10K | 340.60K | 195.20K | -771.40K |
| Total Operating Expenses | 104.05M | 115.83M | 112.83M | 120.05M | 133.77M |
| Operating Income | 74.41M | 72.37M | 85.10M | 85.36M | 89.58M |
| Income Before Tax | 69.56M | 64.16M | 77.71M | 73.46M | 90.96M |
| Income Tax Expenses | 26.24M | 30.84M | 28.27M | 26.77M | 36.59M |
| Earnings from Continuing Operations | 43.31 | 33.31 | 49.43 | 46.69 | 54.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.50K | 18.60K | -72.70K | -75.70K | 45.60K |
| Net Income | 43.32M | 33.33M | 49.36M | 46.61M | 54.42M |
| EBIT | 74.41M | 72.37M | 85.10M | 85.36M | 89.58M |
| EBITDA | 77.36M | 75.58M | 88.51M | 89.16M | 95.00M |
| EPS Basic | 0.42 | 0.33 | 0.50 | 0.49 | 0.58 |
| Normalized Basic EPS | 0.59 | 0.57 | 0.66 | 0.68 | 0.74 |
| EPS Diluted | 0.48 | 0.39 | 0.56 | 0.55 | 0.58 |
| Normalized Diluted EPS | 0.59 | 0.57 | 0.66 | 0.68 | 0.74 |
| Average Basic Shares Outstanding | 412.18M | 404.64M | 395.32M | 386.24M | 377.67M |
| Average Diluted Shares Outstanding | 412.18M | 404.64M | 395.32M | 386.24M | 377.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |